Edwards Lifesciences Net Income 2010-2024 | EW

Edwards Lifesciences annual/quarterly net income history and growth rate from 2010 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Edwards Lifesciences net income for the quarter ending September 30, 2024 was $3.071B, a 697.82% increase year-over-year.
  • Edwards Lifesciences net income for the twelve months ending September 30, 2024 was $4.159B, a 190.65% increase year-over-year.
  • Edwards Lifesciences annual net income for 2023 was $1.402B, a 7.85% decline from 2022.
  • Edwards Lifesciences annual net income for 2022 was $1.522B, a 1.25% increase from 2021.
  • Edwards Lifesciences annual net income for 2021 was $1.503B, a 82.55% increase from 2020.
Edwards Lifesciences Annual Net Income
(Millions of US $)
2023 $1,402
2022 $1,522
2021 $1,503
2020 $823
2019 $1,047
2018 $722
2017 $584
2016 $570
2015 $495
2014 $811
2013 $389
2012 $292
2011 $237
2010 $218
2009 $229
Edwards Lifesciences Quarterly Net Income
(Millions of US $)
2024-09-30 $3,071
2024-06-30 $366
2024-03-31 $352
2023-12-31 $370
2023-09-30 $385
2023-06-30 $307
2023-03-31 $341
2022-12-31 $398
2022-09-30 $344
2022-06-30 $406
2022-03-31 $374
2021-12-31 $335
2021-09-30 $340
2021-06-30 $490
2021-03-31 $338
2020-12-31 $310
2020-09-30 $325
2020-06-30 $-122
2020-03-31 $311
2019-12-31 $280
2019-09-30 $275
2019-06-30 $242
2019-03-31 $250
2018-12-31 $7
2018-09-30 $226
2018-06-30 $283
2018-03-31 $207
2017-12-31 $-3
2017-09-30 $170
2017-06-30 $186
2017-03-31 $230
2016-12-31 $159
2016-09-30 $141
2016-06-30 $127
2016-03-31 $143
2015-12-31 $141
2015-09-30 $118
2015-06-30 $113
2015-03-31 $123
2014-12-31 $109
2014-09-30 $95
2014-06-30 $547
2014-03-31 $60
2013-12-31 $75
2013-09-30 $77
2013-06-30 $93
2013-03-31 $144
2012-12-31 $89
2012-09-30 $69
2012-06-30 $68
2012-03-31 $65
2011-12-31 $63
2011-09-30 $52
2011-06-30 $58
2011-03-31 $64
2010-12-31 $65
2010-09-30 $48
2010-06-30 $58
2010-03-31 $48
2009-12-31 $48
2009-09-30 $74
2009-06-30 $48
2009-03-31 $61
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $41.817B $6.005B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $205.491B 25.07
Intuitive Surgical (ISRG) United States $191.931B 100.35
Alcon (ALC) Switzerland $42.651B 28.54
IQVIA Holdings (IQV) United States $37.469B 20.64
IDEXX Laboratories (IDXX) United States $36.904B 43.46
DexCom (DXCM) United States $30.627B 46.12
Waters (WAT) United States $23.276B 34.42
STERIS (STE) Ireland $21.284B 24.50
SONOVA HOLDING (SONVY) Switzerland $20.097B 0.00
Hologic (HOLX) United States $17.200B 18.58
Fresenius Medical Care AG KGaA (FMS) Germany $14.078B 14.45
Sysmex ADR (SSMXY) Japan $13.104B 41.09
Globus Medical (GMED) United States $11.291B 28.59
Penumbra (PEN) United States $9.244B 90.55
Masimo (MASI) United States $9.076B 43.92
Teleflex (TFX) United States $8.687B 13.85
Glaukos (GKOS) United States $7.647B 0.00
PROCEPT BioRobotics (PRCT) United States $4.828B 0.00
Integer Holdings (ITGR) United States $4.639B 26.30
Veracyte (VCYT) United States $3.314B 99.44
Inari Medical (NARI) United States $3.126B 0.00
LivaNova (LIVN) United Kingdom $2.714B 15.67
Nihon Kohden (NHNKY) Japan $2.347B 17.83
TransMedics (TMDX) United States $2.344B 74.30
Elekta AB (EKTAY) Sweden $2.216B 19.92
Tandem Diabetes Care (TNDM) United States $2.108B 0.00
Integra LifeSciences Holdings (IART) United States $1.881B 9.83
RxSight (RXST) United States $1.599B 0.00
Alphatec Holdings (ATEC) United States $1.363B 0.00
Artivion (AORT) United States $1.216B 80.56
Pulse Biosciences (PLSE) United States $1.152B 0.00
OPKO Health (OPK) United States $1.078B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.852B 14.48
Paragon 28 (FNA) United States $0.837B 0.00
Mesa Laboratories (MLAB) United States $0.712B 16.78
ORTHOFIX MEDICAL INC (OFIX) United States $0.699B 0.00
IRadimed (IRMD) United States $0.693B 37.47
AxoGen (AXGN) United States $0.646B 0.00
Pacific Biosciences Of California (PACB) United States $0.597B 0.00
SiBone (SIBN) United States $0.570B 0.00
OrthoPediatrics (KIDS) United States $0.544B 0.00
Semler Scientific (SMLR) United States $0.515B 30.30
Treace Medical Concepts (TMCI) United States $0.493B 0.00
Tactile Systems Technology (TCMD) United States $0.441B 23.84
ClearPoint Neuro (CLPT) United States $0.404B 0.00
Delcath Systems (DCTH) United States $0.370B 0.00
AngioDynamics (ANGO) United States $0.351B 0.00
CVRx (CVRX) United States $0.331B 0.00
NeuroPace (NPCE) United States $0.327B 0.00
Inogen (INGN) United States $0.227B 0.00
Alpha Tau Medical (DRTS) Israel $0.215B 0.00
Accuray (ARAY) United States $0.210B 0.00
Sight Sciences (SGHT) United States $0.203B 0.00
KORU Medical Systems (KRMD) United States $0.187B 0.00
Nevro (NVRO) United States $0.163B 0.00
Atossa Genetics (ATOS) United States $0.157B 0.00
Sensus Healthcare (SRTS) United States $0.143B 15.26
Spectral Diagnostics (EDTXF) Canada $0.105B 0.00
WORK Medical Technology Group (WOK) China $0.094B 0.00
LENSAR (LNSR) United States $0.090B 0.00
Vicarious Surgical (RBOT) United States $0.089B 0.00
Monogram Orthopaedics (MGRM) United States $0.084B 0.00
EDAP TMS S.A (EDAP) France $0.084B 0.00
908 Devices (MASS) United States $0.083B 0.00
InspireMD (NSPR) Israel $0.082B 0.00
Hyperfine (HYPR) United States $0.073B 0.00
Covalon Technologies (CVALF) Canada $0.071B 0.00
EnVVeno Medical (NVNO) United States $0.053B 0.00
Lucid Diagnostics (LUCD) United States $0.048B 0.00
Rapid Micro Biosystems (RPID) United States $0.045B 0.00
Envoy Medical (COCH) United States $0.044B 0.00
Spectral AI (MDAI) United States $0.038B 0.00
Accelerate Diagnostics (AXDX) United States $0.038B 0.00
Neuronetics (STIM) United States $0.035B 0.00
Adagio Medical Holdings (ADGM) United States $0.034B 0.00
Precision Optics (POCI) United States $0.032B 0.00
NexGel (NXGL) United States $0.025B 0.00
DarioHealth (DRIO) United States $0.023B 0.00
Biosig Technologies (BSGM) United States $0.019B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Ekso Bionics Holdings (EKSO) United States $0.015B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.015B 0.00
Aspira Women's Health (AWH) United States $0.012B 0.00
Baird Medical Investment Holdings (BDMD) $0.012B 0.00
T2 Biosystems (TTOO) United States $0.011B 0.00
QT Imaging Holdings (QTI) United States $0.011B 0.00
PAVmed (PAVM) United States $0.009B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Nuwellis (NUWE) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00